Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Clinical trial NCT01681368 · TERMINATED

Trial details

NCT number: NCT01681368
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Peritoneal Neoplasms Fallopian Tube Neoplasms

Start date: 2012-08-15
Primary completion: 2013-12-09
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.